Blog articles

DNA helix with a piece separated from it in front of a light source

Trial underway for hATTR therapy

The novel ‘one off’ treatment could change the lives of those living with the condition

Key genomic technologies of 2020: treatments old and new

In the second part of our review of the year’s genomic highlights, we look at the breakthroughs that are helping patients with rare disease and cancer
DNA being transcribed to mRNA by the RNA polymerase, and several enzymes within the nucleus of a cell

RNA-based therapies: two types explained

What are RNA therapies and how are they used? We compare the two licensed types – antisense and RNA interference – to find out more

Mitochondrial disease: the genomics challenge

Mitochondrial diseases are overwhelmingly genetic in origin, so why are gene therapies so difficult to develop? We take a deep dive to find out more.

Genome editing trial suggests cure for blood diseases

Recent tests have established a potential cure for sickle cell disease and beta thalassaemia by using genome editing on bone marrow stem cells

Prime editing: the new kid on the block

Progress in the field of gene editing has been rapid, but one relatively new technique could be useful for up to 90% of known disease-causing variants

Genomics and HIV: can we be cured?

New genomic discoveries provide hope that lifelong antiretroviral therapy may one day be a thing of the past

Infectious diseases and the race to diagnosis

Researchers are exploring new techniques to tackle serious infectious diseases, and contain an outbreak before it becomes an epidemic

HIV and the genome

Genome editing has not been without controversies, but some studies suggest it may hold the cure for patients living with HIV

Genomics, the land, and the promise of new drugs

Despite its proven value, scientists and researchers are yet to harness the full medical potential of the soil. Is genomics the key?
Fertilisation IVF

Birth of world’s first gene-edited babies sparks outcry

Why is the procedure so controversial, what are the risks, and could it ever happen in the UK? We take a look at the key issues

First RNA-based therapy approved in US and Europe

Gene-silencing technique works without altering the person’s DNA, and prevents harmful proteins from being made in their cells